Large-scale testing (Phase 3)Active Not RecruitingNCT03319667
What this trial is testing
Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Who this might be right for
Plasma Cell Myeloma
Sanofi 475